Day: September 29, 2025
Next generation sustained-release formulations for a variety of peptides
Executive summaryfirst biocompatible pharmaceutical formulations progress to preclinical models
new sustained-release drug delivery platforms for peptides, melanocortins
aim to predict drug release kinetics from new formulations
liquid formulation allows flexible dosing through adjusting injection volumes
perseverance during 10 years of in-house researchMELBOURNE, Australia, Sept. 28, 2025 (GLOBE NEWSWIRE) — CLINUVEL today announced that it is advancing new sustained-release liquid drug formulations in a preclinical program evaluating various drug release profiles. A decade of investment in fundamental research & development in CLINUVEL’s fully-owned Singaporean laboratories (VALLAURIX) has provided positive, consistent results demonstrating the potential...
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX 4 Product Execution Plan Announced, will be the First Potential Model Under the FX Brand Designed for the Volume Market
Written by Customer Service on . Posted in Public Companies.
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX 4 Product Execution Plan Announced, will be the First Potential Model Under the FX Brand Designed for the Volume MarketFaraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX 4 Product Execution Plan Announced, will be the First Potential Model Under the FX Brand Designed for the Volume MarketFX Super One Middle East Final Launch event will be held on October 28, start of the first deliveries in the Middle East planned for November of this year.
FF and FX will join WETEX 2025 in Dubai from September 30 to October 2, one of the largest and most influential exhibitions for sustainable and clean energy in the Middle East.LOS ANGELES, Sept. 28, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday...